What smart money is saying about IQVIA Holdings Inc
4 funds in our archive have pitched IQVIA Holdings Inc — most recently Artisan U.S. Mid-Cap Value Strategy in March 2026.
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Get an email when a fund writes about it
Position history
Between Q2 2025 and Q3 2026, 6 fund letters reported a position in IQVIA Holdings Inc, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 0 | 0 |
| Q2 2026 | 2 | 0 | 0 | 0 |
| Q1 2026 | 3 | 0 | 0 | 2 |
| Q2 2025 | 0 | 0 | 0 | 2 |
Fund activity · 6 positions
- HoldsAmati Global Innovation FundJuly 2026
“Our holdings in Dexcom and IQVIA were the strongest examples of this, after reporting solid earnings and allaying some of the concerns which we felt were unjustified.”
IQVIA Holdings Inc - June 2026
“IQVIA, one of our largest holdings, is apparently in AI’s cross hairs.”
IQVIA Holdings Inc - June 2026
“The roadkill basket is a hyper-simplified collection of companies that apparently are going to be disrupted by AI. We have seen a number of such baskets circulating among traders. Below is an example of some of the most common names we have seen circulating on these lists: Accenture PLC Adobe Inc Automatic Data Processing Inc Booking Holdings Inc Cognizant Technology Solutions Corp FactSet Research Systems Inc Gartner Inc IQVIA Holdings Inc Paychex Inc The Charles Schwab Corp Given what we know about these names, we suspect that the list was put together by a freshly minted, sleep-deprived MBA feeding prompts into ChatGPT. In the trading world, nuance is out the window. It’s about selling stories. It’s about the inability to disprove the negative. IQVIA, one of our largest holdings, is apparently in AI’s cross hairs.”
IQVIA Holdings Inc - March 2026
“Portfolio Commentary In the first quarter of 2026 the Large Cap Equity composite eked out a gain of 0.57% net of fees compared to a loss of 4.33% for the S&P 500. What became clear is that companies with strong backlogs of customer business were rewarded and those with more economically sensitive customers underperformed. The best contributors were led by Vertiv Holdings Co., Advanced Energy Industries, Inc., and Curtiss- Wright Corporation. All three saw customer order growth adding to already strong backlogs in their respective fields of computing infrastructure, and aerospace/nuclear power. We continue to monitor their business closely for cracks in the foundation but remain confident that they are essential to customers and the prospects for growth are solid. Detractors were led by Estee Lauder Companies Inc. While there remains a strong case for accelerating profit growth based on better execution and a more efficient operation, the combination of the war and its impact on consumer spending, along with a proposed merger with a competitor caused the stock price to reset. We will evaluate whether our 3-5 year thesis is affected by these events. Also detracting was IQVIA Holdings Inc.”
IQVIA Holdings Inc - March 2026
“• IQVIA Holdings was a detractor during the quar- ter.”
IQVIA Holdings Inc - March 2026
“Portfolio Commentary In the first quarter of 2026 the Select Equity composite eked out a gain of 1.17% net of fees compared to a loss of 4.33% for the S&P 500. What became clear is that companies with strong backlogs of customer business were rewarded and those with more economically sensitive customers underperformed. The best contributors were led by Vertiv Holdings Co., Advanced Energy Industries, Inc., and Curtiss- Wright Corporation. All three saw customer order growth adding to already strong backlogs in their respective fields of computing infrastructure, and aerospace/nuclear power. We continue to monitor their business closely for cracks in the foundation but remain confident that they are essential to customers and the prospects for growth are solid. Hardman Johnston Global Advisors LLC®, 300 Atlantic Street, Stamford, CT 06901 T203 324 4722 hardmanjohnston.com 4 Hardman Johnston Select Equity 2 0 2 6 F I R S T QU A R T E R R E P O R T Detractors were led by PayPal Holdings, Inc.. The company has not demonstrated that it can capitalize on what should be strong competitive advantages in the digital payments space, leading us to exit the position. Also detracting was IQVIA Holdings Inc.”
IQVIA Holdings Inc
Fund coverage · 4 theses
- Artisan U.S. Mid-Cap Value StrategyMarch 2026
IQVIA Holdings Inc combines scaled CRO operations with proprietary healthcare data assets that create a durable moat and strong cash flows, with cyclical and AI concerns offering attractive valuation.
Read the full thesis - Broyhill AMMarch 2026
IQVIA is a clinical research organization with sticky pharma demand, proprietary data, and valuation support despite AI concerns.
Read the full thesis - Artisan Global Value StrategyJune 2025
IQVIA is a leading contract research organization that is poised for continued growth despite current industry headwinds, with a robust market share and attractive financial characteristics.
Read the full thesis - Vulcan Value PartnersJune 2025
IQVIA Holdings is the world's largest contract research organization, leveraging its extensive data and services to support drug development and commercialization while navigating current industry challenges.
Read the full thesis
Read every full thesis on IQVIA Holdings Inc
Unlock all 4 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→